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Abstract. 
 
The muscle regulators MyoD and Myf-5 con-
trol cell cycle withdrawal and induction of differentia-
tion in skeletal muscle cells. By immunofluorescence 
analysis, we show that MyoD and Myf-5 expression pat-
terns become mutually exclusive when C2 cells are in-
duced to differentiate with Myf-5 staining present in 
cells which fail to differentiate. Isolation of these undif-
ferentiated cells reveals that upon serum stimulation 
they reenter the cell cycle, express MyoD and downreg-
ulate Myf-5. Similar regulations of MyoD and Myf-5 
were observed using cultured primary myoblasts de-
rived from satellite cells. To further analyze these regu-
lations of MyoD and Myf-5 expression, we synchro-
nized proliferating myoblasts. Analysis of MyoD and 
Myf-5 expression during cell cycle progression revealed 
distinct and contrasting profiles of expression. MyoD is 
absent in G0, peaks in mid-G1, falls to its minimum 
level at G1/S and reaugments from S to M. In contrast, 
Myf-5 protein is high in G0, decreases during G1 and 
reappears at the end of G1 to remain stable until mito-
sis. These data demonstrate that the two myogenic fac-
tors MyoD and Myf-5 undergo specific and distinct cell 
cycle–dependent regulation, thus establishing a correla-
tion between the cell cycle–specific ratios of MyoD and 
 
Myf-5 and the capacity of cells to differentiate: (
 
a
 
) in 
G1, when cells express high levels of MyoD and enter 
differentiation; (
 
b
 
) in G0, when cells express high levels 
of Myf-5 and fail to differentiate.
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C
 
ELL
 
 cycle withdrawal and onset of differentiation
are tightly linked processes that depend on growth
factor activity. During skeletal muscle differentia-
tion, mononucleated proliferating myoblasts stop dividing,
coordinately activate muscle-specific gene expression and
fuse into plurinucleated myotubes. Cell cycle arrest, a pre-
requisite for differentiation, occurs before S phase during
the G1 phase of the cell cycle (Nadal-Ginard, 1978; Clegg
et al., 1987). Except under specific circumstances, termi-
nally differentiated myotubes are unable to reenter the
cell cycle in response to growth factors.
The apparent antagonism between proliferation and dif-
ferentiation implies that signaling pathways driving prolif-
eration must be suppressed to allow induction of differen-
tiation. Indeed, by inactivating G1/S cyclin-dependent
kinase (cdk)
 
1
 
 activity, cyclin-dependent kinase inhibitors
(CKI) such as p21 block cell cycle progression before S
phase (for review see Hunter and Pines, 1994; Walsh and
Perlman, 1997). p21 expression is upregulated during myo-
genesis while, in parallel, cdk activities decline (Guo et al.,
1995; Halevy et al., 1995; Skapek et al., 1995). This p21 up-
regulation has been associated with permanent cell cycle
arrest of muscle cells (Andrés and Walsh, 1996). One tar-
get of the cdk is the retinoblastoma protein (pRb). Inacti-
vation of pRb is required for G1/S progression and occurs
in late G1 as a result of its phosphorylation by cdks (for re-
view see Bartek et al., 1996). In its hypo-phosphorylated
form, pRb prevents S phase entry by sequestering E2F
transcription factors (Chelappan et al., 1991), a family of
proteins essential for G1/S transition. Interestingly, pRb is
found hypophosphorylated in myotubes and it has been
involved in the maintenance of the permanent cell cycle
withdrawal in myotubes (Gu et al., 1993; Schneider et al.,
1994; Novitch et al., 1996).
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During myogenesis, these different cell cycle regulatory
pathways can be antagonized or, in contrast, reinforced by
muscle-specific regulators of the MyoD family. The basic
HLH protein MyoD and related members Myf-5, myoge-
nin, and MRF4 are essential transcriptional activators of
muscle-specific genes required throughout myogenesis
(Weintraub et al., 1991, 1993). Of these four muscle reg-
ulatory factors, only MyoD and Myf-5 are expressed in
proliferating myoblasts (Weintraub, 1993). Interestingly,
overexpression of MyoD directly modulates the cell cycle
of normal and transformed cells by blocking G1/S progres-
sion (Crescenzi et al., 1990; Sorrentino et al., 1990). Differ-
ent mechanisms may explain the cell cycle inhibitory activ-
ity of MyoD. MyoD enhances p21 transcription (Halevy et
al., 1995) ultimately leading to cdks downregulation. Addi-
tionally, the interaction between MyoD and the hypophos-
phorylated form of pRb may maintain pRb in its active
form (Gu et al., 1993). Finally, MyoD has also been shown
to downregulate cyclin B1 expression (Chu et al., 1997).
Conversely, cyclin D1 is upregulated in response to growth
factors and antagonizes the myogenic activity of MyoD
(Rao et al., 1994; Skapek et al., 1995). Thus, it appears that
the decision to differentiate relies on cross-talk between
MyoD and cell cycle signaling pathways. In this context,
slight variations in MyoD expression and/or activity may
change the balance between proliferation and differentia-
tion.
 
 
 
Indeed, in many myogenic cell lines, the capacity of
cell to differentiate appears linked to the level of MyoD
expression (Montarras et al., 1996). In addition, the known
positive inducers of myogenesis such as insulin like growth
factors, thyroid hormones and retinoic acid enhance both
MyoD expression and muscle differentiation (Pinset et al.,
1988; Florini et al., 1991; Carnac et al., 1992; Albagli-Curiel
et al., 1993) implying that a minimal threshold of MyoD
protein must be reached before differentiation can take
place. Consistent with this hypothesis, it has been ob-
served that the amount of immunostained MyoD protein
varies considerably in the nuclei of proliferative myo-
blasts, whereas it is homogeneously high in myotubes
(Tapscott et al., 1988; our own unpublished results).
These observations suggest that the induction of differ-
entiation at a precise time of the cell cycle, presumably
G1, may be related to variations in MyoD level and raises
the question of a potential cell cycle–dependent regulation
of MyoD.
In this report, we show that the expression of MyoD and
Myf-5 (muscle regulatory factors) is mutually exclusive
during differentiation. We have isolated a subpopulation
of undifferentiated myoblasts from differentiated C2 cells
that express high levels of Myf-5 and no MyoD. These
data were also obtained using cultured primary mouse myo-
blasts derived from satellite cells. Upon serum stimulation,
these cells proliferate, reexpress MyoD, and differentiate.
Further, we show that MyoD/Myf-5 ratios appear to be
controlled in a cell cycle–dependent manner. Using a com-
bination of low serum and methionine-depleted medium,
we were able to block cell proliferation without differenti-
ation. The kinetics of cell cycle progression after reentry of
quiescent myoblasts into proliferation reveals a good level
of synchronization. Analysis of the expression pattern of
MyoD and Myf-5 at different phases of cell cycle revealed
that the two myogenic factors undergo specific cell cycle–
 
dependent regulation. Thus, we propose a model where
myoblasts can potentially exit at two different phases of
the cell cycle characterized by their opposing MyoD/Myf-5
ratios and capacity for differentiation.
 
Materials and Methods
 
Reagents and Cell Culture
 
Ham-F12, DME with or without methionine were purchased from Life
Technology/Gibco-BRL (Eragny, France).
 
 
 
FCS came from Institute Boy
(Reims, France). All-
 
trans
 
 retinoic acid was diluted in dimethyl sulfoxide
(DMSO).
C2.7 (a subclone of C2 cells)- and C2-inducible myoblasts (Yaffe and
Saxel, 1977; Pinset et al., 1988) were routinely grown in proliferation me-
dium (a 1/1 mixture of HAM-F12/DME) supplemented with 10% (vol/
vol) FCS and subcultured twice a week. For differentiation, confluent C2
cells were refed with DME plus 2% FCS (“differentiation medium”) for
indicated times. For data shown in Fig. 4 
 
B
 
, the differentiation medium
additionally contained 10
 
2
 
6
 
 M of all-
 
trans
 
 retinoic acid which has been
shown to accelerate entry into differentiation (Albagli-Curiel et al., 1993).
 
Preparation of Primary Mouse Myoblasts Culture
 
This protocol is derived from that of Alterio et al. (1990) and Pinset and
Montarras (1994). Primary myoblasts were prepared from three 6-wk-old
BALBc mice. After sterile dissection, muscles from legs were minced in
PBS supplemented with 200 U/ml of penicillin and 0.2 mg/ml of strepto-
mycin. After three washes muscles were digested with pronase (Boeh-
ringer-Mannheim, Meylan, France) at 0.15%/g of tissue for 90 min with
gentle pipetting every 15 min. After centrifugation at 130 
 
g
 
 for 10 min to
eliminate fragments, mouse primary cells were washed three times in
DME/HAMF12 (1/1) supplemented with 10% FCS by centrifugation at
600 
 
g
 
 for 10 min. Satellite cells were then plated on 35-mm collagen-
coated (Poly-labo, Strasbourg, France) dishes and grown in DME/
HAMF12 (1/1) supplemented with 20% FCS and 2% Ultroser (Bio Sepra
SA, Villeneuve La Garenne, France) for 72–96 h. For differentiation,
DME plus 5% FCS was added for 12 h (see Fig. 3, 
 
e
 
 and 
 
f
 
) and for 3 d (see
Fig. 3, 
 
c
 
, 
 
d
 
, 
 
g
 
, and 
 
h
 
).
 
Synchronization
 
2 
 
3
 
 10
 
4
 
 C2.7- and C2-inducible myoblasts were plated on 35-mm dishes.
24 h after plating, cells were rinsed twice in PBS and then shifted in DME
without methionine supplemented with 1% FCS for 36 h. Quiescent (G0)
myoblasts were allowed to reenter cell cycle by changing the medium to
fresh DME containing 10% FCS. To determine S phase entry, 0.1 mM
5-bromodeoxyuridine (BrdU) was added to the culture during 15 min and
then cells were processed for immunofluorescence analysis. Cells were
also synchronized at the G1/S boundary by adding 1 mM hydroxyurea
(HU; SIGMA, La Verpillère, France) 1 h after release of methionine dep-
rivation and for a total period of 15 h. Cells were then extensively washed
successively in PBS and DME plus 10% FCS. Maximal S phase (after a 15
min BrdU pulse) and M phase were obtained, respectively, 2 and 6 h after
release of HU. Alternatively, quiescent myoblasts were obtained after dif-
ferentiation of cultured myoblasts. Confluent C2 cells and primary mouse
myoblasts were allowed to differentiate for 3 d. On average, 60–70% of
myoblasts fuse and differentiate while 30–40% of myoblasts stop prolifer-
ating but do not differentiate. We found that myotubes are more sensitive
to trypsinization than residual myoblasts. Thus, a short trypsinization
(0.15%, 15
 
0
 
) allows removal of all the myotubes leaving only quiescent un-
differentiated myoblasts still adherent to the culture dishes. These quies-
cent cells were then allowed to reenter the cell cycle by addition of fresh
proliferation medium to the culture.
 
Western Blot Analysis
 
C2 or inducible cells were lysed in 5
 
3
 
 Laemmli buffer (250 mM Tris-HCl,
pH 6.8, 5% SDS, 35% glycerol, 40 mM DTT, and 1% of Bromophenol
blue in ethanol). 50 
 
m
 
g total protein (protein concentrations were deter-
mined using the BioRad DC kit; BioRad, Ivry/Seine, France) were trans-
ferred onto nitrocellulose membranes (Schleicher and Schuell, Dassel,
Germany). Membranes were blocked with PBS containing 5% skimmed
milk and incubated for 1 h with primary antibodies: polyclonal C20 anti- 
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MyoD (from Santa-Cruz, Biotechnology, Santa Cruz, CA) diluted 1/400,
polyclonal anti-Myf-5 directed against the COOH-terminal portion of the
protein, diluted 1/500 both antibodies anti-MyoD and anti-Myf-5 were al-
ready used in Carnac et al. (1998), anti-Myf-5 antibodies were also used in
Auradé et al. (1997) and in Lindon et al. (1998), polyclonal anti-cyclin A
(Girard et al., 1991) diluted 1/400, F5D supernatant anti-myogenin (the
monoclonal antibody F5D developed by Wright et al. [1989] was obtained
from the Developmental Studies Hybridoma Bank [DSHB] developed
under Department of Biological Sciences, Iowa City, IA) diluted 1/5 and
monoclonal DMA1A anti-tubulin (SIGMA) diluted 1/2,000. Membranes
were washed and incubated for 30 min with a peroxidase-conjugated sec-
ondary antibody (Amersham, Les Ulis, France) at a dilution of 1/5,000.
After several washes in PBS, membranes were incubated with chemilumi-
nescence reagents.
 
cdk2 Immunoprecipitation and Histone H1 Assays
 
Synchronized C2 cells (as indicated in Fig. 2 
 
B
 
) were washed twice in 1
 
3
 
PBS and scrapped in 1 ml of PBS. After centrifugation at 3,000 rpm, the
pellets were resuspended in lysis buffer (50 mM Tris, pH 7.4, 150 mM
NaCl, 0,4% NP40, 2 mM EDTA, 50 mM NaF, 10 mM 
 
b
 
-glycerophos-
phate, 1 mM ATP, 2 
 
m
 
g/ml of Leupeptin and Aprotinin, 2 mM Sodium
Vanadate, and 2 mM DTT). After 10 passages through a 21-gauge needle,
cell lysates were cleared by centrifugation at 13,000 rpm. Protein concen-
trations were determined using the BioRad DC kit. 200 
 
m
 
g of extract were
immunoprecipitated with polyclonal anti-cdk2 (M2, used at a 1/50 dilu-
tion; Santa-Cruz Biotechnology). Protein A–Sepharose was added for 1 h
at 4
 
8
 
C. After centrifugation, pellets were washed three times with lysis
buffer, twice in lysis buffer containing 400 mM NaCl and twice in kinase
buffer (25 mM Hepes, pH 7.4, 25 mM MgCl
 
2
 
, 25 mM 
 
b
 
-glycerophosphate,
2 mM DTT, and 0.1 mM NaVO
 
3
 
). Beads containing immunoprecipitated
cdk2 were incubated in 20 
 
m
 
l of kinase buffer containing 50 
 
m
 
M ATP, 5
 
m
 
Ci of 
 
g
 
-[
 
32
 
P]ATP (3,000 Ci/mmol; Amersham) and 2 
 
m
 
g of histone H1
(Boehringer-Mannheim) for 40 min at room temperature. Kinase reac-
tions were stopped by addition of 5 
 
m
 
l of 5
 
3
 
 Laemmli buffer (250 mM
Tris-HCl pH 6.8, 5% SDS, 35% glycerol, 40 mM DTT, and 1% of Bro-
mophenol blue in ethanol), boiled for 5 min before loading onto a 12%
SDS–polyacrylamide gel and transferred to nitro-cellulose membranes
(Schleicher and Schuell). The membranes were first exposed to Kodak
X-ray films (Kodak, Marne La Vallée, France) and then used for Western
blot analyses.
 
Northern Blot Analysis
 
Total RNA was extracted using the guanidinium isothiocyanate/LiCl pro-
cedure as described by Catala et al. (1983). The fractioning of total RNA
and procedures for transfer and hybridization to nylon membranes have
been described in Carnac et al., 1992. Filters were hybridized using the fol-
lowing cDNA probes which were labeled by random priming mouse
MyoD1 (Davis et al., 1987) and human Myf-5 (American Type Culture
Collection, Rockville, MD).
 
Immunofluorescence
 
C2 cells and primary mouse myoblasts were fixed for 5 min in 3.7% for-
malin PBS followed by a 30-s extraction in 
 
2
 
20
 
8
 
C acetone and rehydra-
tion in PBS containing 0.5% BSA. Expression of Myf-5, MyoD, and myo-
genin were analyzed using rabbit polyclonal anti–Myf-5 antibody
(directed against the NH
 
2
 
-terminal portion of the protein diluted 1/300;)
used in Auradé et al. (1997), Carnac et al. (1998), and Lindon et al. (1998),
5.8A mouse monoclonal antibody against MyoD diluted 1/5 (a gift of Drs
P. Dias and P. Houghton, St. Jude Children’s Hospital, Memphis, TN;
Dias et al., 1992) and mouse monoclonal antibody against myogenin (F5D
supernatant anti-myogenin, a gift from Dr. W.E. Wright, Department of
Cell Biology, Vanderbilt University, Nashville, TN). BrdU was detected
using monoclonal anti-BrdU antibody (Amersham). Primary antibodies
diluted in PBS/BSA were incubated for 1 h at 37
 
8
 
C, then washed in PBS,
followed by a 30-min incubation with biotinylated anti-rabbit or fluores-
cein-conjugated anti-mouse antibodies (1/200; Amersham). Biotinylated
antibodies were finally revealed after 30 min incubation with streptavidin–
Texas red (1/200; Amersham). DNA was stained with Hoechst (0.1 
 
m
 
g/ml;
SIGMA).
 
Mitotic Shake Off and Nocodazole Block
 
Mitotic cells from a 80% subconfluent populations of asynchronous C2
cells grown in flasks were mechanically detached by repeated shaking. Su-
pernatants were centrifuged at 1,000 rpm for 7 min and the pellet contain-
ing mitotic cells resuspended in DME plus 10% FCS and plated at 10
 
5
 
cells per 60-mm dish. For Western blot analysis, cells were lysed in Laem-
mli buffer immediately, when mitotic cells are initially collected, point 0,
at 1, 2, 3, 4, and 5 h after mitotic cells have been plated. MyoD and 
 
a
 
-tubu-
lin protein levels were analyzed as previously described (see Western Blot
Analysis). For immunofluorescence analysis, cells were fixed at different
times after reattachment. Cells were subsequently stained for MyoD or
BrdU (after a 15-min BrdU pulse) as described above (see Immunofluo-
rescence).
Dishes of 80% subconfluent populations of asynchronous Inducible C2
cells were treated with 1 
 
m
 
M of Nocodazole (SIGMA) for 14 h. Cells
blocked in pseudo-metaphase were detached by gently shaking and re-
leased from nocodazole by three washes in PBS by centrifugation at 1,000
rpm for 7 min. The pellet was resuspended in DME plus 10% FCS and
plated at 10
 
5
 
 cells per 60-mm dish. For Western blot analysis, cells were
lysed in Laemmli buffer immediately after the three washes and at 2, 4, 6,
and 9 h after release from nocodazole and replating. (In Fig. 8, 
 
cont
 
) rep-
resents proteins from asynchronous proliferative inducible C2 cells.
Myf-5 and 
 
a
 
-tubulin protein levels were analyzed as previously described
(see Western Blot Analysis).
 
ImgCalc Quantification
 
Western blot and Northern blot analyses were scanned and quantified
(see Fig. 9), using ImgCalc sensitivity software (developed by N.J.C.
Lamb, details upon request) on a Silicon Graphics Indigo 2 workstation.
 
Results
 
The Expression of MyoD and Myf-5 Defines Two 
Populations of Cells in Differentiated C2 Myoblasts and 
Primary Mouse Myoblasts
 
To assess the possible link between the expression of
MyoD and Myf-5 and cell cycle withdrawal leading into
differentiation, we examined MyoD and Myf-5 levels dur-
ing C2 cells differentiation by coimmunofluorescence
staining for MyoD and Myf-5 and for Myf-5 and myoge-
nin, an early marker of differentiation (Wright et al.,
1989). As shown in Fig. 1 
 
A 
 
(
 
a
 
 and 
 
b
 
), exponentially grow-
ing cells can coexpress MyoD and Myf-5 whereas Myf-5,
and MyoD expression are mutually excluded in differenti-
ated cells with Myf-5 immunoreactivity being only de-
tected in a subpopulation of mononucleated cells and not
in multinucleated myotubes (Fig. 1 
 
A
 
, 
 
c
 
 and 
 
d
 
). Costaining
for Myf-5 and myogenin shows that Myf-5 positive cells do
not express the differentiation marker myogenin (Fig. 1 
 
A
 
,
 
e
 
 and 
 
f
 
) and are apparently quiescent as judged by the ab-
sence of DNA synthesis (unpublished observations). In
contrast, MyoD protein is mostly found in multinucleated
myotubes expressing myogenin and is absent from Myf-5
positive cells (unpublished observations and Fig. 1 
 
A
 
, 
 
c
 
and 
 
d
 
). These data show that when cells exit from the cell
division cycle and enter differentiation, the expression
profiles of MyoD and Myf-5 become mutually exclusive in
contrast to proliferating myoblasts. These data are in
agreement with a report analyzing Myf-5 and MyoD im-
munostaining during in vitro muscle differentiation (Lin-
don et al., 1998).
Immunofluorescence on Fig. 1 
 
A
 
 shows a cytoplasmic
staining for Myf-5 in differentiated cells (
 
d
 
 and 
 
e
 
). To
check if this cytoplasmic staining was specific for Myf-5,
we have examined the patterns of Myf-5 and MyoD pro-
teins by comparative Western blot analysis of the de-
tached myotubes versus residual nondifferentiated cells. 
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The population of adherent myoblasts was enriched by re-
moving most if not all myotubes after short trypsinization
of the differentiated culture (see Materials and Methods
and Fig. 1 
 
B
 
, 
 
top
 
). Western blot analysis in Fig. 1 
 
B
 
 reveals
that residual cells are not differentiated since they do not
express the early differentiation marker myogenin. These
cells clearly express Myf-5 but not MyoD. An opposite
pattern is observed for detached myotubes that contain a
high level of myogenin and MyoD but little or no Myf-5.
This result suggests that the cytoplasmic staining observed
for Myf-5 in myotubes results from a nonspecific signal.
This was confirmed by preincubating Myf-5 antibody with
GST-Myf-5 before immunofluorescent staining of differ-
entiated C2 cells. Such preincubation only suppressed the
nuclear staining but not the cytoplasmic staining for Myf-5
(unpublished observations). Together with the immuno-
blot in Fig. 1 
 
B
 
, these data show that myotubes do not con-
tain Myf-5.
To investigate whether the loss of MyoD expression ob-
served in differentiation-deficient myoblasts was an irre-
versible process or a cell cycle–dependent event, residual
cells were stimulated with serum. As shown in Fig. 2 
 
A 
 
re-
sidual adherent cells do not express either the myogenic
marker myogenin (as previously shown on Fig. 1 
 
B
 
), or cy-
clin A, an early marker of S phase (Girard et al., 1991)
suggesting they are quiescent. These undifferentiated and
nonproliferative myoblasts can be induced to reenter the
cell cycle upon addition of fresh proliferation medium to
the culture for 24 h as attested by the upregulation of cy-
clin A expression (Fig. 2 
 
A
 
). When subsequently placed in
differentiation medium for 48 h, these cells undergo ap-
parently normal differentiation and reexpress myogenin
(Fig. 2 
 
A
 
). Western blotting of MyoD and Myf-5 expres-
sion was carried out at different times after refeeding re-
sidual quiescent myoblasts with serum-containing me-
dium. MyoD, absent from quiescent myoblasts, peaks 6 h
after addition of fresh medium and then decreases by 12 h,
before the appearance of cyclin A which is first detected
by 15 h (Fig. 2 
 
B
 
 and data not shown). In contrast, Myf-5
that is expressed in quiescent cells decreases as cells reen-
ter the cell cycle.
To examine if our observations could be extended be-
yond the C2 cells “in vitro” system, to other myogenic cell
populations, primary mouse myoblasts culture was per-
formed. We examined MyoD and Myf-5 levels during pri-
mary mouse myoblasts proliferation and differentiation by
coimmunofluorescence staining for MyoD and Myf-5, and
for Myf-5 and myogenin. As shown in Fig. 3 (
 
a
 
 and 
 
b
 
), ex-
ponentially growing cells can coexpress MyoD and Myf-5
whereas Myf-5 and MyoD expression are mutually ex-
cluded in differentiated cells with Myf-5 immunoreactivity
being only detected in a subpopulation of mononucleated
cells and not in multinucleated myotubes (Fig. 3, 
 
c
 
 and 
 
d
 
).
Costaining for Myf-5 and myogenin shows that Myf-5 pos-
itive cells do not express the differentiation marker myo-
genin (Fig. 3, 
 
e
 
–
 
h
 
) and that this mutual exclusion occurs as
soon as 12 h of differentiation (Fig. 3, 
 
e
 
 and 
 
f
 
). In contrast,
MyoD protein is mostly found in multinucleated myotubes
expressing myogenin and is absent from Myf-5 positive
cells (Fig. 3, 
 
c
 
 and 
 
d
 
 and data not shown). Therefore, as
previously shown for C2 cells (Fig. 1 
 
A
 
), the expression
profiles of MyoD and Myf-5 become mutually exclusive
during primary mouse myoblasts differentiation allowing
two populations to be defined. One population of undif-
ferentiated cells expressing high levels of Myf-5 without
MyoD, in contrast to the other population of differenti-
Figure 1. Analysis of MyoD,
Myf-5 and myogenin reveal
two populations of myoblasts
with different commitment
to differentiation. (A) Coim-
munofluorescence analysis of
MyoD and Myf-5 in expo-
nentially growing C2 cells (a
and b) and in differentiated
cells after 3 d in differentia-
tion medium (c and d). Dif-
ferentiated cells were also
analyzed by costaining for
Myf-5 with myogenin (e and
f). Arrowed in c and d are
mononucleated cells express-
ing Myf-5 with no MyoD and
arrowed in e and f are cells
expressing Myf-5 that are de-
void of myogenin. (B) Lim-
ited trypsinization of differ-
entiated cells gave rise to two
populations of cells: residual
adherent cells and detached
myotubes (top). Western
blot analysis of these two
populations was carried out for myogenin, MyoD, Myf-5, and
a-tubulin (bottom). Bar, 10 mM. 
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ated cells expressing MyoD without Myf-5. These primary
mouse myoblasts also reinduced MyoD expression (with a
concomitant decrease of Myf-5) after myotubes removal
(by mild trypsinization) and serum stimulation of residual
quiescent cells (as for C2 cells, see Fig. 2 B, unpublished
observations). These results confirm the correlation be-
tween the potential of cells to differentiate and their ratios
of Myf-5 and MyoD expression.
Taken together, these results show that C2 myoblasts as
well as cultured primary mouse myoblasts, express differ-
ent ratios of MyoD and Myf-5 correlated to their potential
to differentiate: myoblasts containing high levels of Myf-5
appear quiescent and fail to differentiate whereas myo-
blasts expressing high levels of MyoD are differentiated.
These data also show that the expression of both MyoD
and Myf-5 proteins is regulated upon reentry of quiescent
cells into proliferation and thus must be subject to cell cy-
cle–dependent regulation.
Methionine Deprivation Blocks C2 Myoblast 
Proliferation without Induction of Differentiation
To determine the impact of cell cycle on MyoD and Myf-5
gene expression, we needed to produce highly synchro-
nized muscle cells. Although a number of procedures have
been developed for establishing synchronous cultures of
mammalian cells in G0/G1, many of these protocols, based
on serum starvation to block cell proliferation, are not ap-
plicable in muscle cells because they induce differentiation
(Krek and DeCaprio, 1995). To obtain myoblasts in a qui-
escent state but without entry into the differentiation
pathway, we used two methods based on manipulation of
medium conditions. We used Ham F12 nutrient mixture, a
poor medium for myogenic induction (Pinset and Whalen,
1984) and methionine-depleted medium since methionine
is an essential amino acid required for growth but not for
cell viability (Nadal-Ginard, 1978). C2 myoblasts were
grown in Ham F12 supplemented with 1% serum, or in
methionine-depleted DME medium plus 1% serum. After
36 h, cells were pulse labeled with BrdU which is incorpo-
Figure 2. Differentiation-deficient myoblasts isolated from dif-
ferentiated cells can reinduce MyoD and reactivate the differenti-
ation program. C2 cells were allowed to differentiate for three
days in differentiation medium. Mononucleated myoblasts were
isolated after removing the population of myotubes after a short
trypsinization of the culture. (A) Western blot analysis was car-
ried out for cyclin A, myogenin, and a-tubulin on protein extracts
from the total differentiated cells before trypsinization (Diff.), re-
sidual adherent cells after trypsinization (residual), residual cells
refed for 24 h with serum-containing medium (residual cells 1
prolif.) or residual cells first refed with proliferation medium for
24 h and then switched to differentiation medium for 2 d (residual
cells 1 diff.). (B) Adherent residual cells were allowed to reenter
the cell cycle by adding serum-containing medium to the culture.
Protein extracts at the indicated times after refeeding with prolif-
eration medium were analyzed by Western blotting for MyoD,
Myf-5, and a-tubulin expression.
Figure 3. Coimmunofluorescence analysis of MyoD, Myf-5, and
myogenin reveal two populations of myoblasts in mouse primary
cells with different commitment to differentiation. Coimmunoflu-
orescence analysis of MyoD and Myf-5 and in exponentially
growing mouse primary myoblasts (a and b) and in differentiated
cells after 3 d in DME 5% FCS (c and d). Coimmunofluorescence
analysis of Myf-5 and myogenin in satellite cells differentiated for
12 h (e and f) and for 3 d (g and h). Arrowed in c and d are mono-
nucleated cells expressing Myf-5 with no MyoD and arrowed in
e–h are cells expressing Myf-5 which are devoid of myogenin.
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rated into DNA during DNA synthesis and thus allows the
identification of cells undergoing S phase. Cells were then
fixed and processed for immunofluorescence analysis us-
ing monoclonal antibodies directed against BrdU or myo-
genin. In Ham F12 plus 1% serum, cells showed some in-
corporation of BrdU (10–15% of cells are BrdU positive;
Fig. 4 A, a and b) and tend to differentiate as shown by the
significant proportion of myogenin positive cells (10% of
cells are myogenin positive; Fig. 4 A, c). Myoblasts grown
in methionine-depleted DME 1 1% serum do not incor-
porate BrdU and therefore appear to be quiescent (Fig. 4
A, d and e). In contrast to cells treated with low serum
only, these cells do not differentiate as judged by the lack
of myogenin positive nuclei (Fig. 4 A, f). Thus, amino acid
deprivation allowed efficient arrest of muscle cells in a
quiescent and nondifferentiated state.
To verify that such quiescent myoblasts retain the ability
to either proliferate or differentiate, C2 cells cultured for
36 h in methionine-depleted medium were incubated with
either proliferation or differentiation medium for 15 h in
the presence of BrdU. Cells were then analyzed for BrdU
incorporation or myogenin expression by immunofluores-
cence. As shown in Fig. 4 B, addition of differentiation
medium to quiescent myoblasts is accompanied by a sig-
nificant induction of myogenin (50–60% of cells are myo-
genin positive) and only limited progression into S phase
(5–10% of cells are BrdU positive; Fig. 4 B, g and h). In
contrast, quiescent myoblasts refed with proliferation
medium passed through S phase (50–60% of cells are
BrdU positive) and do not expressed myogenin (Fig. 4 B,
i and j).
These results demonstrate that mouse C2 myoblasts can
be efficiently arrested by methionine deprivation in a qui-
escent state without any induction of differentiation. This
growth arrest is reversible since quiescent C2 myoblasts
can either reenter proliferation or undergo differentiation
depending on extracellular signals received.
Characterization of C2 Myoblasts Cell Cycle
To analyze MyoD and Myf-5 expression during the cell cy-
cle, initial experiments were performed to assess accu-
rately the proportion of cells in a given phase of the cell
cycle. We estimated the percentage of cells entering S
phase and the length of S phase by measuring the incorpo-
ration of BrdU using immunofluorescence analysis. For
this purpose, myoblasts cultured in methionine-depleted
medium were refed with proliferation medium and at the
time indicated thereafter, were pulse-labeled for 15 min
with BrdU, before fixation and immunofluorescence treat-
ment for detection of BrdU incorporation. As shown in
Fig. 5 A, the first BrdU positive cells are detected 12–14 h
after refeeding and for the next 5–6 h, with a peak of 50%
cells incorporating BrdU by 16 h after refeeding. The ma-
jority of cells have progressed through S phase by 18 h af-
ter refeeding. Beyond this time, ,20% of the myoblasts
are still BrdU positive indicating that DNA synthesis is
nearly completed, as confirmed by entry into mitosis 20 h
Figure 4. Methionine depri-
vation efficiently arrests
mouse C2 myoblasts in a qui-
escent and nondifferenti-
ated state. (A) 2 3 104 C2
cells were plated on 35-mm
dishes, grown in prolifera-
tion medium for 24 h and
then were further grown for
36 h either in Ham F12 me-
dium supplemented 1% se-
rum (a–c) or in methionine-
depleted medium plus 1%
serum (d–f). At the end of
this incubation time, cells were further incubated for 15 min with
0.1 mM BrdU (a and b) and then processed for immunofluores-
cence analysis using antibodies directed against BrdU to probe
for DNA synthesis (a and d) or myogenin to probe for differenti-
ation (c and f). Total nuclei corresponding to the cells described
in a and d were revealed after DNA staining with Hoechst (b and
e). (B) C2 cells cultured for 36 h in methionine-depleted medium 1
1% FCS were then incubated for 15 h in either differentiation me-
dium (g and h) or proliferation medium (i and j; see Materials and
Methods) for 15 h in presence (g and i) or absence (h and j) of 0.1
mM BrdU. Cells were then fixed and processed for immunofluo-
rescence analysis using antibodies against BrdU (g and i) or myo-
genin (h and j). Bar, 10 mM.Kitzmann et al. Cell Cycle–dependent Regulation of MyoD and Myf-5 1453
that cells enter S phase successively and not synchro-
nously, most likely due to their variable length of G1
phase. Drugs such as hydroxyurea (HU) prevent DNA
replication and have been successfully used to synchronize
cells at G1/S boundary. HU block is fully reversible and al-
lows progression into S phase synchronously (Lamb et al.,
1992; for review see Krek and DeCaprio, 1995). Thus, to
resynchronize C2 myoblasts at the G1/S boundary, quies-
cent (G0) cells were treated with HU during G1 progres-
sion, by addition of HU from 1 to 15 h after release from
methionine deprivation. To estimate the length of S phase,
cells were pulse labeled with BrdU for 15 min at different
times after released from HU treatment and analyzed for
BrdU incorporation by immunofluorescence analysis. As
shown in Fig. 5 B, .90% of cells went through S phase in a
period that does not exceed 4 h after release from HU
block, with a peak between 1 and 3 h. 6 h after HU release,
40% of myoblast entered mitosis. This mitotic index is ex-
tremely high considering that mitosis itself is an event
which lasts ,1 h. Therefore, C2 myoblast synchronization
by double-block (G0-methionine deprivation and G1/S-
HU block) allows accurate determination of the length of
the different cell cycle phases: G1 spreads from 0 to 12–
14 h after refeeding, followed by 2–3 h of S phase and 3–4 h
of G2 before cells reach mitosis, representing a total
length for C2 cell cycle of 20–22 h after release from a qui-
escent state. The efficiency of synchronization during G1
and G1/S was also evaluated by measuring the histone H1
activity of cdk2 which is maximal at the end of G1 and G1/S
transition (Pagano et al., 1993). This kinase was immuno-
precipitated from quiescent myoblasts, at different times
after release from methionine deprivation and from HU-
treated cells, to assay for its kinase activity against histone
H1. The efficiency of immunoprecipitation was deter-
mined by Western blot analysis. As expected, the histone
H1 activity of cdk2 is not detected in quiescent cells and is
strong 10 to 12 h after refeeding in late G1 cells (Fig. 5 C).
In HU-blocked cells, cdk2 histone H1 activity is identical
to that in late G1 cells, indicating that HU treatment effi-
ciently blocked cells at the G1/S boundary (Fig. 5 C).
Together, these data show that we developed a method
allowing effective synchronization of muscle cells and pro-
duction of cells synchronized in a given phase of their cell
division cycle.
Cell Cycle Dependence of MyoD and Myf-5 Expression
To analyze the expression of MyoD and Myf-5 in the
course of the cell cycle, proteins and mRNA extracts were
prepared from synchronized myoblasts at different times
after release from methionine deprivation and from HU
block. Western blot analysis revealed that MyoD protein
is barely detectable in G0, peaks in the middle of G1, then
decreases at the end of G1, before the appearance of cy-
clin A to reincreases until mitosis (Fig. 6 A). Using HU
block to better synchronize cells in the second half of their
division cycle, we confirm that MyoD is low or absent at
the G1/S boundary and reincreases as cells progress
through S phase (Fig. 6 B). Therefore, MyoD appears to
undergo a bimodal pattern of expression in the course of
one division cycle after release from quiescence, with a
peak in the middle of G1 and at the end of G2. In contrast
Figure 5. C2 myoblasts can be efficiently and accurately synchro-
nized in a precise phase of their cell division cycle. Asynchronous
C2 cells were arrested in quiescence by incubation in methionine
depleted medium containing 1% serum for 36 h. Reentry into the
cell cycle was allowed by refeeding them with proliferation me-
dium. At different times after refeeding, cells were pulse-labeled
for 15 min with BrdU before fixation and analysis for BrdU in-
corporation by immunofluorescence. (A) Plotted values repre-
sent the percentage of cells positive for BrdU incorporation
(empty circles) and the percentage of mitotic cells (filled squares)
over the total population of cells at given times after restimula-
tion. (B) Cells, made quiescent by methionine deprivation, were
induced to proliferate with serum containing medium and HU
was added from 1 to 15 h after refeeding, allowing cells to
progress through G1. Cells were subsequently released from HU
block by washing off the HU and addition of serum containing
medium, pulse-labeled for 15 min with BrdU and processed for
immunofluorescence analysis at the indicated times. The percent-
age of cells in S phase was determined by counting BrdU positive
cells over the total number of cells (empty circles). The percent-
age of mitotic cells is also plotted (filled squares). Percentages in
A and B were determined after counting .300 cells for each
point. (C) cdk2 protein was immunoprecipitated from quiescent
myoblasts at different times after release from methionine depri-
vation and from G1/S blocked myoblasts which were released
15 h after the addition of HU as in B (see Material and Methods).
cdk2 kinase activity was evaluated against histone H1. Shown is
an autoradiograph of the radioactivity incorporated into histone
H1 and a Western blot analysis of the same membrane probed
for anti-cdk2. Times above are in hours after refeeding. Synchro-
nized cells with HU block are marked G1/S.
after refeeding. Quiescent myoblasts are thus able to un-
dergo normal cell cycle progression upon serum refeeding.
However, the pulses of BrdU incorporation show that the
peak of S phase is large, spreading over 8 h. This indicatesThe Journal of Cell Biology, Volume 142, 1998 1454
to MyoD, Myf-5 protein level is high in quiescent myo-
blasts, decreases to barely detectable level during early G1
phase, and reappears at the end of G1 before cyclin A to
remain stable until mitosis (Fig. 6, A and B). HU block re-
veals that Myf-5 is effectively maintained as myoblasts go
through S and G2 phases but tends to decrease in G2/M
(Fig. 6 B). The cell cycle–dependent changes in MyoD
protein are well correlated with the level of MyoD mRNA
which show a low level in G0, a peak in early G1, a down-
regulation in late G1 and a slight increase during progres-
sion into G2/M phase (Fig. 6 C). Myf-5 mRNA is present
at high level in G0 myoblasts and decreases during the G0/
G1 transition to remain relatively unchanged during the
rest of cell cycle progression. This constant level of Myf-5
mRNA seen after G1 suggests that posttranscriptional
mechanisms must be also involved in the upregulation of
Myf-5 protein observed at the end of G1 and as DNA syn-
thesis proceeds (Fig. 6 C).
Together these data show that the expressions of MyoD
and Myf-5 are subject to opposite cell cycle–dependent
regulation in dividing myoblasts in particular as cells come
out of quiescent G0-stage. To assess the changes in MyoD
protein in cell cycling without passing through a G0 quies-
cent stage, i.e., from M to G1 phase, we performed mitotic
shake off experiments. Exponentially growing myoblasts
Figure 6. MyoD and Myf-5 are subject to different cell cycle–
dependent regulation. C2 myoblasts cultured with methionine-
depleted medium containing 1% serum were refed with prolifera-
tion medium. Proteins (A and B) and mRNA (C) were extracted
at different times after refeeding. (A) Western blot analysis of
proteins extracted from G0 to 20 h. Similar membranes were
blotted for cyclin A, Myf-5, MyoD, and a-tubulin (an internal
loading control). (B) To analyze the expression of proteins in the
second part of the cell cycle, i.e., from G1/S to G2/M, cells were
resynchronized after methionine starvation by incubation in HU
for 15 h in proliferation medium. Shown is the expression of cy-
clin A, Myf-5, MyoD, and a-tubulin in resynchronized cells: S,
G2, and G2/M represent cells fixed 2, 4, and 6 h, respectively, af-
ter release from HU. (C) mRNA expression was analyzed in G1
cells (G0 to 8 h after refeeding) and in cells resynchronized in
S-phase with HU (G1/S to G2/M). Expression of Myf-5 and
MyoD mRNA is shown with homogeneity in RNA loading dem-
onstrated by revealing ribosomal RNA after ethidium bromide
staining.
Figure 7. Analysis of MyoD expression after mitotic shake off re-
veals rapid changes in its expression. The expression profile for
MyoD was also assessed in the course of normal cell cycle. Mi-
totic cells, detached by repeated shakes, were allowed to attach
and grown for different times prior (a) to a 15-min pulse labeling
with BrdU to assess S-phase (b) immunofluorescence analysis to
assess the proportion of MyoD positive cells, (c) Western blotting
to assess the amount of MyoD. (A) Comparative percentage of
MyoD-expressing cells and of cells positive for BrdU incorpora-
tion after immunofluorescence analysis. (B) Immunofluores-
cence analysis photomicrographs of replated myoblasts stained
for MyoD at different times after mitotic shake off. Shown are
cells stained for MyoD (top) and the same cells stained for DNA
with Hoechst (bottom). (C) Protein extracts, from cells replated
after mitotic shake off and grown for 1–5 h, were analyzed for
MyoD expression (top) and a-tubulin as an internal control (bot-
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were subject to repeated shake off to detach the popula-
tion of cells in mitosis. Detached cells were subsequently
allowed to reattach in dishes and analyzed by immunoflu-
orescence at the time indicated for MyoD expression and
for BrdU incorporation to determine exactly the entry
into S phase. Mitotic cells progress very quickly into the
next cell cycle reaching the S phase 4 h after the initial
shake off (Fig. 7 A) and entering mitosis 10–12 h after the
shake off (unpublished observations). The total length of
C2 myoblasts cycle between two mitosis is therefore 10–12
h, in complete agreement with the doubling time in a cul-
ture of growing C2 myoblasts, which we have measured to
be 12 h (unpublished observations). It is worth noting that
the length of G1 phase determined after release from the
quiescent state exceeds by z6 h the estimated G1 phase
after the mitotic shake off (12 and 4 h, respectively; com-
pare Figs. 5 and 7). However, quiescent cells have to go
through an exceeding 6–8-h period to exit from G0 (for re-
view see Zetterberg et al., 1995), thus explaining the 6-h
difference between the length of G1 after G0 or mitosis.
During the first hour after the mitotic shake off, the per-
centage of MyoD-expressing cells observed by immuno-
fluorescence is very high, between 80–90%, then drops
markedly to 40% 2 h after shake off and reincreases to
80% at 4 h when cells entered S phase and remains high as
cells progress into S phase (Fig. 7, A and B). To confirm
these observations, Western blot analyses were performed
on mitotic cells harvested immediately after the shake off
and 1, 2, 3, 4, and 5 h after reattachment. Immunoblot
analysis shown in Fig. 7 C confirms the data obtained by
immunofluorescence: the expression of MyoD is high dur-
ing the first hour after the initial shake off, drops markedly
at 2 h and then reincreases between 3 to 5 h post shake off.
Thus, MyoD expression is maintained at high levels at the
M to G1 transition. The pattern of expression observed
during progression from G1 to S is similar to that observed
in G0-synchronized myoblasts (see Fig. 6) and shows that
in continuously cycling cells, MyoD is also downregulated
before entry into S.
The respective patterns of MyoD and Myf-5 expression
during cell cycle progression are clearly different suggest-
ing that their expression may be controlled by distinct reg-
ulatory pathways. However, since it has been reported
that MyoD can repress Myf-5 expression both in vivo and
in vitro (Rudnicki et al., 1992; Montarras et al., 1996), the
downregulation of Myf-5 we observed during early G1
may be due to a suppressive effect of MyoD high expres-
sion. To test this possibility, we used a C2-derived variant,
termed inducible-C2 (IND-C2; Pinset et al., 1988). Unlike
parental C2 cells, inducible myoblasts do not express
MyoD at the myoblast stage and fail to differentiate spon-
taneously in the absence of added insulin. However,
these differentiation-deficient myoblasts do express Myf-5
(Montarras et al., 1996). We have investigated the cell cy-
cle variation of Myf-5 in inducible-C2 cells after double
synchronization by methionine deprivation and HU block
as done for the parental cells. Western blot analysis shows
that these cells are highly synchronized as attested by the
appearance of cyclin A as DNA synthesis proceeds (Fig. 8
A). In such synchronized cell extracts, Myf-5 expression
pattern is similar to that described above for parental cells:
Myf-5 is already expressed in G0, decreases to barely de-
tectable in early G1 phase and after a rise in G1/S, remains
at a high level from S to mitosis (compare Fig. 8 A with
Fig. 6). Thus, it appears clear that the cell cycle–specific
modulation of Myf-5 protein level occurs independently of
MyoD.
We have investigated the oscillation of Myf-5 expression
in randomly growing (i.e., without starvation) inducible
cells by blocking cells with nocodazole (which blocks cells
at the pseudometaphase stage; Fig. 8 B). Western blot
analysis shows that Myf-5 protein level is largely de-
creased in pseudometaphase arrested cells (Fig. 8 B, noco
block) compared with Myf-5 protein level in randomly
growing IND C2 cells (Fig. 8 B, cont) as previously shown
by Lindon et al. (1998). After release from nocodazole,
Myf-5 expression progressively increased. In light of this,
we believe a drop in Myf-5 level takes place between G2
and G1 and, in growing cells, this time window is relatively
short.
Discussion
Effective synchronization of dividing C2 myoblasts al-
lowed us to examine accurately the expression patterns of
the key myogenic regulators MyoD and Myf-5 at specific
Figure 8. Cell cycle variation
of Myf-5 occurs indepen-
dently of MyoD and Myf-5
expression declines only in
mitosis in cycling cells. (A)
To examine if the cyclic pat-
tern of Myf-5 expression was
associated with the changes
in MyoD expression, we ex-
amined Myf-5 expression
pattern in inducible C2 cells,
a variant of C2 cells which express Myf-5 but not MyoD (see Materials and Methods). Cells were synchronized by methionine depriva-
tion and HU block as for the C2 parental cells (see Fig. 5). Protein extracts were analyzed by Western blot analysis for cyclin A, Myf-5
and a-tubulin expression at indicated times, in G1 cells (G0 to 8 h after refeeding) and in cells resynchronized in S-phase with HU (G1/
S to G2/M). (B) To examine Myf-5 expression in the course of a nonarrested cell cycle, inducible C2 cells were blocked with nocodazole
and Myf-5 expression pattern was analyzed after release from nocodazole (at the indicated times) in comparison with nocodazole
blocked cells (0) and asynchronous cells (cont). Protein extracts were analyzed by Western blot analysis for Myf-5 and a-tubulin expres-
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phases of the myoblast cell cycle. Both MyoD and Myf-5
protein levels fluctuated in a cell cycle–dependent fashion
although their expression patterns differed as myoblasts
progressed through the different cell cycle phases (see Fig.
9). MyoD expression peaked in mid G1 whereas Myf-5
showed maximal protein levels in G0 and G2 cells. There-
fore during G1, a time when cells may potentially exit the
cell cycle and enter differentiation (Nadal-Ginard, 1978),
myoblasts display the highest expression of MyoD accom-
panied by low levels of Myf-5. Such a MyoD/Myf-5 ratio
might represent a prerequisite for the initiation of differ-
entiation. Importantly, this conclusion could be extended
beyond the C2 cell line system, to primary mouse myo-
blasts derived from adult muscle, i.e., satellite cells.
Serum and Amino Acid Starvation Represent a 
Reproducible Means for Synchronizing Myoblasts
Under standard growth conditions, removal of serum
growth factors from proliferating myoblasts coincides with
the withdrawal of myoblasts from the cell cycle and initia-
tion of myogenesis. We have described for the first time a
reproducible method for synchronizing myoblasts without
inducing entry into myogenesis. We used a combination of
methionine deprivation and serum starvation to block
muscle cells in a quiescent (G0) stage without concomitant
induction of differentiation. Such G0 arrested myoblasts
retained the potential to either reenter proliferation or un-
dergo differentiation in a manner dependent on extracel-
lular signaling. After stimulation, G0 arrested myoblasts
progress through the cell cycle expressing key cell cycle
regulators, with kinetics identical to those described for
nontransformed fibroblasts (Girard et al., 1991; Lamb et
al., 1992). This artificially induced quiescent state appears
identical to a naturally occurring quiescence found in pop-
ulations of myoblasts that failed to differentiate after
myogenic induction and can be isolated by limited tryp-
sinization to remove differentiated cells. These residual at-
tached cells can subsequently enter into proliferation or
differentiation upon appropriate stimulation.
Use of synchronized C2 cells as a model to study muscle
cell cycle is further supported by our observations that,
like C2 cells, primary mouse myoblasts allowed to differ-
entiate retain a subpopulation of undifferentiated cells
that can be reinduced to proliferate or differentiate (data
not shown). Moreover, MyoD and Myf-5 expression pat-
terns appeared similar in both systems, with Myf-5 ex-
pressed at its highest level and MyoD absent in arrested
cells. This ratio is reversed as cells reenter the cell cycle or
differentiate. These similarities suggest that the conclu-
sions of the study we have carried out in C2 cells can be
validly extended to primary myoblasts isolated from adult
mouse muscle.
Peak Expression of MyoD Coincides with the Initiation 
of Myogenesis
Heterogeneous levels of MyoD expression in asynchro-
nous myoblasts was first observed by Tapscott et al. (1988)
who hypothesized a possible link between cell cycle transit
and variations in MyoD expression. We demonstrate here
that MyoD expression is indeed modulated by cell cycle–
dependent events in proliferating myoblasts. We have
shown that MyoD is induced at the G0/G1 transition, peak
in mid G1 and after falling to a minimum level coincident
with entry into S-phase, MyoD levels are maximal as cells
pass through mitosis and early G1 of a new cell cycle.
After the upregulation at the G0/G1 transition, we show
that MyoD expression drops to its minimal level at the end
of G1, before S phase entry. Interestingly, when MyoD is
ectopically expressed and thus artificially maintained dur-
ing G1, cells do not progress into S phase and thus appear
stopped in G1 (Crescenzi et al., 1990; Sorrentino et al.,
1990; Thorburn et al., 1993). Together with these reports
using ectopic expression of MyoD, our data imply that
downregulation of MyoD in late G1 is a prerequisite point
for further cell cycle progression into S phase. As such,
MyoD, like pRb (Bartek et al., 1996) and the cdk inhibitor
p27kip1 (Polyak et al., 1994; Coats et al., 1996), may par-
ticipate in the establishment of a restriction point (defined
as a point beyond which cell cycle progression becomes in-
dependent of growth factors; Zetterberg et al., 1995) in
muscle cells and thereby control the decision to proliferate
or differentiate.
We observed a second peak of MyoD expression in late
G2/M phase. Since cell cycle exit and induction of differ-
entiation only take place in G1 (Nadal-Ginard, 1978) and
in any case in late G2/mitosis, MyoD activity must be sup-
pressed at this period of the cell cycle. One way to inhibit
MyoD activity may be phosphorylation, as MyoD is a
phosphoprotein (Tapscott et al., 1988). We observed that
MyoD is hyperphosphorylated during mitosis and that
Figure 9. Schematic representation of the cell cycle related
changes in MyoD and Myf-5, with the potential links to the ca-
pacity of muscle cells to differentiate. Entry into differentiation
occurs in G1 phase of muscle division cycle as determined by
Nadal-Ginard (1978). The values plotted of MyoD and Myf-5
from G1/S boundary to G2/M were drawn from double block
synchronization (first block in G0 after methionine deprivation,
second block in G1/S after HU treatment), whereas the values
plotted for G0 and G1 were drawn from single G0 block. Arbi-
trary units correspond to the relative protein levels of MyoD or
Myf-5 corrected for loading variations using a-tubulin immuno-
blot as a control. Error bars represent maximal variations for
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cdc2-cyclinB (active during mitosis; Nurse, 1994) is most
likely implicated in this phosphorylation (M. Kitzmann,
M. Vandromme, V. Schaeffer, G. Carnac, J.C. Labbé, N.
Lamb, and A. Fernandez, manuscript in preparation).
This cell cycle–dependent expression of MyoD empha-
sizes the fact that MyoD is the muscle regulatory factor
primarily responsible for the initiation of differentiation.
Therefore, a strong expression of MyoD in G1 phase of
the cell cycle may define a “time-window” in which differ-
entiation can take place (Fig. 9).
MyoD and Myf-5 Are Nonredundant Muscle 
Regulatory Factors
We found that cells positive for differentiation markers
expressed MyoD and not Myf-5 whereas cells that remain
undifferentiated expressed Myf-5 and were devoid of
MyoD. The expression profile observed for Myf-5 during
G0 and G1 phases of the cell cycle, high in G0 and mini-
mal during G1, is exactly opposite to the pattern seen
for MyoD expression. Interestingly although Myf-5 and
MyoD expression patterns closely coincide in these two
systems, they differ from those observed in cells released
from mitosis after mitotic shake off or nocodazole block.
A number of significant differences exists between G0/G1
and M/G1 transitions. In cells sychronized by mitotic
shake off, we observed a rapid entry into S phase (G1 last-
ing from 4–5 h), in contrast to that observed when cells
exit from G0 after serum refeeding (G1 of 12–14 h). That
the length of G1 after serum arrest differs from that ob-
served in cells passing from M to G1 has previously been
described (Zetterberg et al., 1995). This difference defines
an “early G1”, a 6–8-h period necessary to exit G0, which
corresponds to the time required to reinitiate de novo
gene expression and protein synthesis. Absence of this
“early G1” explains why neither the first peak of MyoD
expression nor the downregulation of Myf-5 can be ob-
served in randomly growing cells. As such, in actively rep-
licating myoblasts, MyoD is high in M and G2 whereas
Myf-5 drops to its minimal level during M phase.
Lindon et al. (1998) reported a specific phosphorylation
and degradation of Myf-5 during mitosis in cells blocked
by nocodazole treatment in pseudometaphase. This result
led them to propose that cycling cells need to degrade
Myf-5 during mitosis to enter into a new cell cycle. In
agreement with these observations, we detected the lowest
levels of Myf-5 protein in nocodazole blocked cells. Post-
translational modulation of Myf-5 may control the up reg-
ulation of Myf-5 protein we observed during G1/S transi-
tion when the level of Myf-5 mRNA appeared to remain
constant. In summary, in growing cells, MyoD level drops
before S-phase and Myf-5 at mitosis.
Differentiated, synchronized and growing cells give rise
to the same result, MyoD and Myf-5 have distinct and op-
posite cell cycle–dependent regulation. Overexpression of
either Myf-5 or MyoD in a fibroblast background was suf-
ficient to induce muscle differentiation. Although Myf-5
overexpression may induce endogenous MyoD expres-
sion, this observation led to the notion that Myf-5 and
MyoD performed overlapping and redundant functions in
myogenesis (Weintraub, 1993). From the data we have
presented here, this is clearly not the case since the pro-
teins are not coexpressed during the early stages of cell cy-
cle progression.
MyoD and Myf-5 Upstream Regulatory Pathways
It is likely that the induction of MyoD expression during
G0/G1 progression that is seen for both protein and
mRNA, is controlled by growth factor signaling cascades.
Although some growth factors inhibit both the expression
of MyoD and its activity, several specific growth factors
such as insulin like growth factor, fibroblast growth factor
6, and transforming growth factor b are required for
MyoD expression (Florini et al., 1991; Filvaroff et al.,
1994; Montarras et al., 1996; Floss et al., 1997). In addition,
we have recently shown that the GTPase RhoA, which is
activated by serum and by several growth factors, is re-
quired for MyoD expression (Carnac et al., 1998).
While MyoD has been shown to inhibit Myf-5 (Rudnicki
et al., 1992; Montarras et al., 1996), we report here that a
similar downregulation of Myf-5 during early G1 also oc-
curs in myoblasts devoid of MyoD. Therefore, the low lev-
els of Myf-5 seen in G1 are not due to a suppressive effect
of the concomitant upregulation of MyoD. It appears that
forced expression of a high level of Myf-5 is incompatible
with cell proliferation (Auradé et al., 1994; our unpub-
lished results). Consistent with these observations G0 ar-
rested myoblasts expressed high level of Myf-5 whereas
reentry into proliferation was accompanied by a decrease
in Myf-5 protein. Recently, Lindon et al. (1998) reported a
similar low level of Myf-5 protein during G1 phase in a C2-
derived cell line that does not express MyoD. However,
the data reported by these authors on Myf-5 in G0 myo-
blasts is less clear, with apparently a low level in G0
whereas we found that Myf-5 expression is at its highest
level in quiescent myoblast. Such discrepancy might be ex-
plained by the poor efficiency of “G0” synchronization
achieved in the study by Lindon et al. (1998) as judged by
the presence of a significant proportion of proliferating
cells in the “G0” population (see FACS® analysis in Fig.
4). In myoblasts, quiescence is associated with exclusive
Myf-5 expression raising the question of the role of Myf-5
in keeping muscle precursor cells in their determined
state. Further investigations using synchronized cells may
help to answer this question.
Role of MyoD and Myf-5 Cell Cycle–dependent 
Regulation during Muscle Regeneration
In vivo observations reveal that mature muscles possess a
population of mononucleated myoblasts located on their
surface. These satellite cells are normally quiescent in the
adult and do not express differentiation markers (Smith et
al., 1994; Yablonka-Reuveni and Rivera, 1994). They can
reenter cell cycle in response to fiber damage, possibly in
response to released mitogens (Schultz and Jaryszak, 1994;
Smith et al., 1994; Floss et al., 1996) and proliferate before
differentiating into new muscle cells. The release from G0
arrest using the method we developed for myoblasts syn-
chronization appears to closely mimic the process of rein-
duction of satellite cell proliferation before regeneration.
Single cell analysis by Cornelison and Wold (1997) con-
cluded that a subset of freshly isolated satellite cells ex-
pressed either MyoD or Myf-5 and that 24 h after cell cul-The Journal of Cell Biology, Volume 142, 1998 1458
ture, satellite cells could coexpress MyoD and Myf-5. This
observation is consistent with our results where satellite
cells may be found principally at two points along the cell
cycle. In G0 as cells express Myf-5 without MyoD and in
mid G1 as cells express MyoD and withdraw from cell cy-
cle into differentiation. When these satellite cells enter
into proliferation, they will coexpress MyoD and Myf-5 as
we observed during S and G2 in C2 myoblasts.
Clearly, our data imply that mechanisms leading to a
specific activation or downregulation of MyoD and Myf-5
during muscle regeneration is tightly linked with cell cy-
cle–dependent events. These events can now be further in-
vestigated in C2 cells knowing that this cell system reliably
reflects the situation found in cultured primary myoblasts
derived from satellite cells.
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